Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27(KIP1) and MMP3 expression
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jin, Xun | - |
dc.contributor.author | Jin, Xiong | - |
dc.contributor.author | Sohn, Young-Woo | - |
dc.contributor.author | Yin, Jinlong | - |
dc.contributor.author | Kim, Sung-Hak | - |
dc.contributor.author | Joshi, Kaushal | - |
dc.contributor.author | Nam, Do-Hyun | - |
dc.contributor.author | Nakano, Ichiro | - |
dc.contributor.author | Kim, Hyunggee | - |
dc.date.accessioned | 2021-09-06T05:07:48Z | - |
dc.date.available | 2021-09-06T05:07:48Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2013-01-28 | - |
dc.identifier.issn | 0304-3835 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/104171 | - |
dc.description.abstract | Aberrant epidermal growth factor receptor (EGFR) signaling is a typical oncogenic signature in glioblastoma. Here, we show that EGFR inhibition in primary glioma stem cells (GSCs) with oncogenic EGFRvIII and EGFRvIII-transduced glioma stem-like cells promotes invasion by decreasing ID3 levels. ID3 suppresses GSC invasiveness by inhibiting p27(KIP1)-RhoA-dependent migration and MMP3 expression. Xenograft and human glioblastoma specimens show that ID3 localizes within glioblastoma cores, whereas p27(KIP1) and MMP3 are predominantly expressed in glioma cells in invasive fronts. Together, our findings show that EGFR inhibition induces GSC invasiveness by abolishing ID3-mediated inhibition of p27(KIP1) and MMP3 expression. (C) 2012 Elsevier Ireland Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.subject | GROWTH-FACTOR RECEPTOR | - |
dc.subject | PHASE-II TRIAL | - |
dc.subject | GLIOBLASTOMA-MULTIFORME | - |
dc.subject | KINASE INHIBITORS | - |
dc.subject | MALIGNANT GLIOMAS | - |
dc.subject | CYCLE PROGRESSION | - |
dc.subject | TUMOR SUPPRESSION | - |
dc.subject | CANCER | - |
dc.subject | PHOSPHORYLATION | - |
dc.subject | PROLIFERATION | - |
dc.title | Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27(KIP1) and MMP3 expression | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Sung-Hak | - |
dc.contributor.affiliatedAuthor | Kim, Hyunggee | - |
dc.identifier.doi | 10.1016/j.canlet.2012.09.005 | - |
dc.identifier.scopusid | 2-s2.0-84870313535 | - |
dc.identifier.wosid | 000313138000007 | - |
dc.identifier.bibliographicCitation | CANCER LETTERS, v.328, no.2, pp.235 - 242 | - |
dc.relation.isPartOf | CANCER LETTERS | - |
dc.citation.title | CANCER LETTERS | - |
dc.citation.volume | 328 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 235 | - |
dc.citation.endPage | 242 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | GROWTH-FACTOR RECEPTOR | - |
dc.subject.keywordPlus | PHASE-II TRIAL | - |
dc.subject.keywordPlus | GLIOBLASTOMA-MULTIFORME | - |
dc.subject.keywordPlus | KINASE INHIBITORS | - |
dc.subject.keywordPlus | MALIGNANT GLIOMAS | - |
dc.subject.keywordPlus | CYCLE PROGRESSION | - |
dc.subject.keywordPlus | TUMOR SUPPRESSION | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | PHOSPHORYLATION | - |
dc.subject.keywordPlus | PROLIFERATION | - |
dc.subject.keywordAuthor | Glioma stem cells | - |
dc.subject.keywordAuthor | Glioblastoma | - |
dc.subject.keywordAuthor | EGFR | - |
dc.subject.keywordAuthor | ID3 | - |
dc.subject.keywordAuthor | Invasion | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.